(Q40251055)

18 September 2017

Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors (English)

1 reference

Herpes simplex virus type 1

18 September 2017

1 reference

1 reference

S Yamamoto

1

1 reference

18 September 2017

L A Deckter

2

1 reference

18 September 2017

K Kasai

3

1 reference

18 September 2017

E A Chiocca

4

1 reference

18 September 2017

Y Saeki

5

1 reference

18 September 2017

27 July 2006

1 reference

18 September 2017

1 reference

18 September 2017

13

1 reference

18 September 2017

1731-1736

1 reference

18 September 2017

24

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302831

18 September 2017

0 references

cites work

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

RNA viruses as virotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Luciferase Imaging of a Neurotropic Viral Infection in Intact Animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Peculiarities of herpes simplex virus (HSV) transcription: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Bioluminescent indicators in living mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Optical imaging of Renilla luciferase reporter gene expression in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Advances in in vivo bioluminescence imaging of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

MRI of transgene expression: correlation to therapeutic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

A strict-late viral promoter is a strong tumor-specific promoter in the context of an oncolytic herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

7 January 2021

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

7 January 2021

Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

7 January 2021

Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302831

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302831

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference